e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Allergy and immunology of asthma and beyond
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analogs of Asp f 1 (αsarcin, mitogillin and restrictocin) on the diagnosis and stage assessment of allergic bronchopulmonary aspergillosis
J. Mohovic, P. Giavina-Bianchi, Jr., L. K. Arruda, M. Barros, J. Kalil (São Paulo, Ribeirão Preto, Brazil)
Source:
Annual Congress 2008 - Allergy and immunology of asthma and beyond
Session:
Allergy and immunology of asthma and beyond
Session type:
Thematic Poster Session
Number:
3741
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Mohovic, P. Giavina-Bianchi, Jr., L. K. Arruda, M. Barros, J. Kalil (São Paulo, Ribeirão Preto, Brazil). Analogs of Asp f 1 (αsarcin, mitogillin and restrictocin) on the diagnosis and stage assessment of allergic bronchopulmonary aspergillosis. Eur Respir J 2008; 32: Suppl. 52, 3741
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Allergic bronchopulmonary aspergillosis (ABPA) prevalence in adult cystic fibrosis (CF) patients. Usefulness of recombinant Aspergillus fumigatus IgE (rAsp f) in diagnosis and monitoring treatment
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012
Complex treatment of allergic bronchopulmonary aspergillosis (ABPA) in asthmatic patient including anti-IgE therapy – A case report
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012
Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 237s
Year: 2003
IgE expression in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2013 –Asthma
Year: 2013
Allergic bronchopulmonary aspergillosis and other fungal diseases
Source: Eur Respir Mon 2011; 52: 97-114
Year: 2011
Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2003 Oct 01;22(4):592-595
Year: 2003
Prevalence of possible severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) in a UK secondary care hospital
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
Vitamin D deficiency in asthma patients with allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Clinical presentation in 12 patients with allergic bronchopulmonary aspergillosis
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Elevated CEA levels in sera in patients with allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease?
Source: Eur Respir Rev 2010 19: 261-263
Year: 2010
Treating allergic bronchopulmonary aspergillosis: the way forward
Source: Eur Respir J 2016; 47: 385-387
Year: 2016
Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2014; 43: 1487-1500
Year: 2014
Bronchopulmonary aspergillosis
Source: Respipedia Article
Year: 2017
Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Allergic bronchopulmonary aspergillosis (ABPA) by
Aspergillus flavus
Source: Eur Respir J 2001; 18: Suppl. 33, 218s
Year: 2001
Long term follow up of the lung function in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA).
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Serum level directed itraconazole therapy in allergic bronchopulmonary aspergillosis
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
Itraconazole and allergic bronchopulmonary aspergillosis: long-term follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 432s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept